Infinium Pharmachem Limited — Board Meeting, 14-11-2024: Outcome of Board Meeting

The Board of Directors of Infinium Pharmachem Limited has reviewed and approved the standalone and consolidated financial results for the half year ended September 30, 2024. Standalone total income reported is ₹7241.17 crore, with a profit before tax of ₹559.60 crore. For consolidated results, total income is ₹8406.21 crore, leading to a profit before tax of ₹647.11 crore. Additionally, the board approved the allotment of 16,67,000 equity shares via preferential issue and established a Stakeholder Relationship Committee.